77 results on '"Torres, Joana"'
Search Results
2. EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
3. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.
4. Biomonitoring of a population of Portuguese workers exposed to lead
5. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?
6. Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
7. Mo1873 AUTOANTIBODIES TARGETING INTEGRIN αVβ6 ARE ELEVATED IN PSC-IBD AND ALIGN WITH LIVER DISEASE SEVERITY.
8. Sa1809 INTESTINAL ULTRASOUND CORRELATES WITH CLINICAL, BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC BIOMARKERS IN PATIENTS WITH ULCERATIVE COLITIS: A CROSS-SECTIONAL STUDY.
9. 1093 EXPOSURE TO AN INFLAMMATORY PRENATAL ENVIRONMENT AND THE RISK OF INFLAMMATORY BOWEL DISEASE IN THE OFFSPRING: A POPULATION-BASED COHORT STUDY.
10. Evaluation of genotoxicity in a group of workers from a petroleum refinery aromatics plant
11. Editorial/introduction to special issue
12. Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease—One Step Closer to Precision Medicine?
13. The Road to Prognostication? A Five-Protein Panel Predicting Disease Course in Inflammatory Bowel Disease.
14. Preclinical disease and preventive strategies in IBD.
15. Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
16. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
17. Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at Diagnosis.
18. Selecting the Ideal Candidate for Anti-TNF Discontinuation in Crohn's Disease, Dream or Reality?
19. Early Life Greenspace and the Risk of Pediatric-Onset Inflammatory Bowel Disease: Insights into the Link Between Environmental and Human Health.
20. Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
21. Tu1735 TREATMENT OUTCOME OF TOFACITINIB DOSE REDUCTION TO 5 MG TWICE DAILY (BID) VS REMAINING ON 10 MG BID IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION ON 10 MG BID: UPDATED 30 MONTH DATA FROM THE DOUBLE-BLIND, RANDOMIZED RIVETING...
22. Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of the literature.
23. Evidence for Life Before Inflammatory Bowel Disease.
24. Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.
25. Su1556: MATERNAL INFLAMMATORY BOWEL DISEASE DIAGNOSIS BUT NOT GENETIC DETERMINANTS OF THE DISEASE RISK PREDICT FECAL CALPROTECTIN LEVELS DURING EARLY LIFE.
26. Su1509: THE IMPACT OF DISEASE DURATION AND EARLY BIOLOGIC TREATMENT ON TRANSMURAL HEALING IN CROHN'S DISEASE.
27. Sa1607: DISEASE CLEARANCE IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH AMINOSALYCILATES.
28. 612: THE BREASTMILK PROTEOMICS OF WOMEN WITH INFLAMMATORY BOWEL DISEASE (IBD) AND ITS IMPACT ON FECAL CALPROTECTIN AND MICROBIOTA COMPOSITION IN THEIR BABIES.
29. 463: EPSTEIN BARR VIRUS (EBV) EXPOSURE PRECEDES CROHN'S DISEASE DEVELOPMENT.
30. Point-of-Care Intestinal Ultrasound Examination: Prime Time for the Management of Ulcerative Colitis?
31. Reply.
32. Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair
33. Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy.
34. You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
35. Prediction of Inflammatory Bowel Disease: A Step Closer?
36. Neonatal Life Events and the Risk of Inflammatory Bowel Disease.
37. Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
38. Sa509 RISK FACTORS ASSOCIATED WITH FAMILIAL INFLAMMATORY BOWEL DISEASE.
39. Neonatal Exposures and Risk of Inflammatory Bowel Disease: When Does the Clock Start Ticking?
40. 5-Aminosalicilates: Old Habits Die Hard.
41. Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
42. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
43. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
44. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
45. Integrating signalling inputs with chromatin regulators to direct tissue regeneration or tumorigenesis.
46. Sa1841 - Hypertrophic and Constrictive Ileal Strictures in Crohn's Disease: A Histomorphometric Analysis of Two Distinct Entities.
47. 1062 - Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life.
48. Sa1852 - High Risk of Pouch Dysplasia in IBD-PSC Patients Following Total Proctocolectomy.
49. Su1941 - Anti-Microbial Antibodies and Inflammatory Markers are Present in the Serum of Patients with IBD Years Before Diagnosis and can Predict Disease.
50. Tu1810 - Peripheral Arterial Disease is Associated with an Increased Risk of Elderly-Onset Inflammatory Bowel Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.